148 related articles for article (PubMed ID: 37754668)
1. CD5+ Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Presenting as an Asymptomatic Nodule.
Xiao A; Beatty CJ; Choudhary S; Akilov OE
Hematol Rep; 2023 Sep; 15(3):513-517. PubMed ID: 37754668
[TBL] [Abstract][Full Text] [Related]
2. Indurated Plaques on the Legs: Think Lymphoma.
Watts-Santos A; Cuellar-Barboza A; Ramos-Cavazos CJ; Villarreal-Martinez A; Ocampo-Candiani J; Herz-Ruelas ME
Acta Dermatovenerol Croat; 2021 Jul; 29(2):114-115. PubMed ID: 34477080
[TBL] [Abstract][Full Text] [Related]
3. CD5-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type.
Papoudou-Bai A; Marinos L; Vassou A; Kapsali E; Kanavaros P
Case Rep Dermatol Med; 2019; 2019():3730915. PubMed ID: 30792929
[TBL] [Abstract][Full Text] [Related]
4. Double expressor and double/triple hit status among primary cutaneous diffuse large B-cell lymphoma: a comparison between leg type and not otherwise specified subtypes.
Lucioni M; Pescia C; Bonometti A; Fraticelli S; Moltrasio C; Ramponi A; Riboni R; Roccio S; Ferrario G; Arcaini L; Goteri G; Berti E; Paulli M
Hum Pathol; 2021 May; 111():1-9. PubMed ID: 33548250
[TBL] [Abstract][Full Text] [Related]
5. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type with significant T-cell immune response.
Graham PM; Richardson AS; Schapiro BL; Saunders MD; Stewart DM
JAAD Case Rep; 2018 May; 4(4):305-309. PubMed ID: 29693055
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers.
Lucioni M; Berti E; Arcaini L; Croci GA; Maffi A; Klersy C; Goteri G; Tomasini C; Quaglino P; Riboni R; Arra M; Dallera E; Grandi V; Alaibac M; Ramponi A; Rattotti S; Cabras MG; Franceschetti S; Fraternali-Orcioni G; Zerbinati N; Onida F; Ascani S; Fierro MT; Rupoli S; Gambacorta M; Zinzani PL; Pimpinelli N; Santucci M; Paulli M
Cancer Med; 2016 Oct; 5(10):2740-2755. PubMed ID: 27665744
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
[TBL] [Abstract][Full Text] [Related]
9. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type on the Dorsal Foot in a Senior Woman: A Case Report.
Kelly J; Mirkin G; Yim J; Hao X
J Am Podiatr Med Assoc; 2022; 112(6):. PubMed ID: 36525320
[TBL] [Abstract][Full Text] [Related]
10. High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Schrader AMR; Jansen PM; Vermeer MH; Kleiverda JK; Vermaat JSP; Willemze R
Am J Surg Pathol; 2018 Nov; 42(11):1488-1494. PubMed ID: 30113335
[TBL] [Abstract][Full Text] [Related]
11. Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg type.
Kraft RM; Ansell SM; Villasboas JC; Bennani NN; Wang Y; Habermann TM; Thanarajasingam G; Lester SC; Macon W; Inwards DJ; Porrata LF; Micallef IN; Witzig TE; Thompson CA; Johnston PB; Nowakowski GS; Lin Y; Paludo J
Hematol Oncol; 2021 Dec; 39(5):658-663. PubMed ID: 34453851
[TBL] [Abstract][Full Text] [Related]
12. Bone involvement in primary cutaneous diffuse large B-cell lymphoma, leg-type.
Laurent C; Ram-Wolff C; Ingen-Housz-Oro S; Beylot-Barry M; Barete S; Saillard C; Dupuy A; Bagot M; Adamski H
Clin Exp Dermatol; 2023 Feb; 48(2):116-120. PubMed ID: 36730524
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas.
Uccella S; Goteri G; Maiorana A; Donati V; Tibiletti MG; Magnoli F; Facchi S; Merchiori D; Morsia E; Papotti R; Bettelli S; Forti E; Galimberti S; Rupoli S; Filosa A; Dardanis D; Bomben R; Braglia L; Pozzi S; Sacchi S
Hum Pathol; 2023 Jun; 136():44-55. PubMed ID: 36997030
[TBL] [Abstract][Full Text] [Related]
14. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, With Spontaneous Regression After Biopsy.
Marrero-Alemán G; Montenegro-Dámaso T; Peñate Y
Am J Dermatopathol; 2017 Oct; 39(10):785-787. PubMed ID: 28926365
[TBL] [Abstract][Full Text] [Related]
15. A Perplexing Case of Recurrent Abscess-Like Lesions: Insights Into Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Bin Waqar SH; Zaman U; Salahi N; Gupta R; McFarlane IM
Cureus; 2021 Sep; 13(9):e17766. PubMed ID: 34659977
[TBL] [Abstract][Full Text] [Related]
16. Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas.
Schrader AMR; de Groen RAL; Willemze R; Jansen PM; Quint KD; van Wezel T; van Eijk R; Ruano D; Tensen CP; Hauben E; Woei-A-Jin FJSH; Busschots AM; van den Berg A; Diepstra A; Vermeer MH; Vermaat JSP
Virchows Arch; 2022 Mar; 480(3):667-675. PubMed ID: 35028710
[TBL] [Abstract][Full Text] [Related]
17. Diffuse large B cell lymphoma CD5-positive arising in an immune deficiency and immune dysregulation setting: A case report and brief review of the literature.
Cristian M; Baz RA; Stoica AG; Așchie M; Ghinea MM; Deacu M; Boșoteanu M; Mitroi AF; Dobrin N; Iordache IE; Bălțătescu GI
Medicine (Baltimore); 2023 Feb; 102(8):e33083. PubMed ID: 36827036
[TBL] [Abstract][Full Text] [Related]
18. Germinal Centre-Related Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: Report of a Remission Case.
Liu F; Qi F; Zhang X; Cao M; Peng S
Clin Cosmet Investig Dermatol; 2022; 15():1265-1269. PubMed ID: 35821763
[TBL] [Abstract][Full Text] [Related]
19. The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases.
Plaza JA; Kacerovska D; Stockman DL; Buonaccorsi JN; Baillargeon P; Suster S; Kazakov DV
Am J Dermatopathol; 2011 Oct; 33(7):649-55; quiz 656-8. PubMed ID: 21937906
[TBL] [Abstract][Full Text] [Related]
20. TOX expression in cutaneous B-cell lymphomas.
Schrader AM; Jansen PM; Willemze R
Arch Dermatol Res; 2016 Aug; 308(6):423-7. PubMed ID: 27180090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
